Prices delayed by at least 15 minutes | Print

Live UK pricing:

Valirx PLC (VAL)

ORD 0.1P
Sell: 0.12p|Buy: 0.14p|Change: 0 (0%)

Open 

0.13p


Previous close 

0.13p


Trade high 

0.135p


Volume 

1,475,119


Year high 

0.55p


Year low 

0.12p


Dividend yield 

–


Market capitalisation 

£1.72 mn


P/E ratio 

–


ISIN 

GB00BLH13C52


This investment is listed on the Alternative Investment Market (AIM). Investments on this market can be higher risk and have lower liquidity, meaning they can be harder to buy or sell, and their prices may be more volatile. Before investing, make sure you understand the risks of investing.

Share price

Performance 16/10/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Valirx PLC 0.00
FTSE AIM All Share+ 1.05
More...

Company profile

ValiRx PLC is a UK-based biopharmaceutical and life sciences company focused on advancing cutting-edge therapies in healthcare. The Company mainly engages in developing technologies and products in oncology therapeutics and diagnostics, with a focus on the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. It develops therapeutics across fields in oncology and has a portfolio of products in the pipeline, including GeneICE for Silencing Rebellious Genes, VAL201 for prostate cancer, VAL401 for lung cancer, VAL301, BC201, CLX001, and other drug candidates in different stages of development.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
16/10/202604:26:340.1352,2593.05
16/10/202603:27:250.1213500,000606.50
16/10/202612:02:420.1233,33640.00
16/10/202610:47:300.122530,00036.75
16/10/202610:11:070.1265909,5241,150.55

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.